questionText: To ask the Secretary of State for Health and Social Care, what steps her Department is taking to address regional disparities in access to newer treatments for Graft-versus-host disease.
answerText: The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether new medicines represent a clinically- and cost-effective use ...
heading: Graft versus Host Disease: Medical Treatments